Overall rank by patents
#3,627
Across all tracked assignees
USPTO PatentsView assignee record - 101 granted patents across 4 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).
The verdict
Hm.clause holds 101 US patents across 4 technology areas, rank #3,627 of 50,000 tracked assignees.
Hm.clause, Inc. has been granted 101 US utility patents between 2015 and 2025, placing Hm.clause, Inc. at rank #3,627 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.4 claims per patent with primary concentration in A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). As a US Corporation, Hm.clause, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Hm.clause sits between Curna, Inc. (101 patents, rank #3,623) and Nanolumens Acquisition, Inc. (101 patents, rank #3,631) - the closest US assignees by grant volume. The composite Innovation Score of 45.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 60 grants, compared with 41 in the 2015–2019 window, a +46% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Hm.clause, Inc.'s 24.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hm.clause, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CuRNA, Inc.
101 patents
DELPHI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.R.L.
101 patents
FCI Americas Technology LLC
101 patents
Fameccanica.Data S.p.A.
101 patents
James Hardie Technology Limited
101 patents
LUCAS AUTOMOTIVE GMBH
101 patents
LaCrosse Footwear, Inc.
101 patents
Nanolumens Acquisition, Inc.
101 patents
HM.CLAUSE, INC.
101 patents
What this shows Hm.clause holds 101 patents at rank #3,627, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,627 in granted patent volume.
Other assignees with the most granted patents in Hmclause's primary technology class.
Hm.clause's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
45 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.0% |
| 2016 | 5 | 5.0% |
| 2017 | 6 | 5.9% |
| 2018 | 13 | 12.9% |
| 2019 | 16 | 15.8% |
| 2020 | 8 | 7.9% |
| 2021 | 8 | 7.9% |
| 2022 | 14 | 13.9% |
| 2023 | 10 | 9.9% |
| 2024 | 13 | 12.9% |
| 2025 | 7 | 6.9% |
Top 4 of 4 technology areas
Overall rank by patents
#3,627
Across all tracked assignees
45.4 out of 100
How to use this portfolio
Hm.clause's 101 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.